摘要
目的探讨血清总前列腺特异抗原(PSA)、结合PSA(CPSA)含量及CPSA/PSA比值在诊断前列腺癌中的作用。方法用化学发光免疫分析检测前列腺癌患者(48例)、前列腺增生患者(86例)和其他疾病患者(43例)血清PSA和CPSA含量,计算CPSA/PSA比值,将患者分组进行比较。结果前列腺癌组PSA、CPSA和CPSA/PSA均显著高于前列腺增生和其他疾病组(P<0.01)。结论血清PSA、CPSA含量及CPSA/PSA比值是前列腺癌诊断的重要指标。
Objective To study the value of PSA, CPSA and CPSA/PSA in the diagnosis of prostate carcinoma. Methods Serum PSA and CPSA levels were determined with CLIA in 48 prostate carcinoma patients with, 86 benign prostatic hyperplasia patients and 43 controls. Ratio-of CPSA to PSA was calculated. Results Serum PSA, CPSA and CPSA/PSA levels in patients with prostate carcinoma were significantly higher than those in benign prostatic hyperplasia and controls. Conclusion PSA , CPSA and CPSA/PSA are the most important tumor markers of prostate carcinoma.
出处
《安徽医科大学学报》
CAS
北大核心
2006年第4期454-456,共3页
Acta Universitatis Medicinalis Anhui
关键词
前列腺肿瘤/诊断
癌
prostatic neoplasms/diagnosis
carcinoma
